• Kenneth C Cummings, Maureen Keshock, Ravindra Ganesh, Alana Sigmund, Deanne Kashiwagi, Jagan Devarajan, Paul J Grant, Richard D Urman, and Karen F Mauck.
• Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, OH. Electronic address: cummink2@ccf.org.
• Mayo Clin. Proc. 2021 May 1; 96 (5): 1342-1355.

AbstractThe widespread use of complementary products poses a challenge to clinicians in the perioperative period and may increase perioperative risk. Because dietary supplements are regulated differently from traditional pharmaceuticals and guidance is often lacking, the Society for Perioperative Assessment and Quality Improvement convened a group of experts to review available literature and create a set of consensus recommendations for the perioperative management of these supplements. Using a modified Delphi method, the authors developed recommendations for perioperative management of 83 dietary supplements. We have made our recommendations to discontinue or continue a dietary supplement based on the principle that without a demonstrated benefit, or with a demonstrated lack of harm, there is little downside in temporarily discontinuing an herbal supplement before surgery. Discussion with patients in the preoperative visit is a crucial time to educate patients as well as gather vital information. Patients should be specifically asked about use of dietary supplements and cannabinoids, as many will not volunteer this information. The preoperative clinic visit provides the best opportunity to educate patients about the perioperative management of various supplements as this visit is typically scheduled at least 2 weeks before the planned procedure.Copyright © 2020 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

14 keywords...

hide…